Expanded Program for Immunization, a Missed Opportunity for Postpartum Family Planning Utilization

NCT ID: NCT04780243

Last Updated: 2021-03-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

1474 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-02-01

Study Completion Date

2021-03-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is aimed to enhance postpartum family planning by integrating family planning information with infant immunization services, which is the most widely utilized health services globally.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study, a before-and-after type of quasi-experimental study will be conducted in purposely selected health centers Sidama region, Ethiopia. base line assessment of postpartum contraceptive utilization rate will be done which will be followed by an intervention. The intervention consists of screening, counseling for family planning and referring mothers coming for infant immunization services to family planning units. All mothers coming for infant immunization service will be screened for and counseled for family planning and those who will be voluntary to take any method will be referred to family planning unit. All mothers who will not be voluntary will be re-counseled by the next visit.

Finally, the effect of this intervention on postpartum contraceptive utilization rate will be reassessed. The expected outcome will be to see an improved contraceptive uptake during the first year after delivery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Contraceptive Usage

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SEQUENTIAL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pre-intervention group

Pre-intervention group: women participated during the base line assessment will be labeled as Pre-intervention group

Group Type NO_INTERVENTION

No interventions assigned to this group

postintervention group

Postintervention group: women participated after the intervention was initiated will be labeled as postintervention group.

Group Type EXPERIMENTAL

counseling

Intervention Type OTHER

Mothers presented to infant immunization units are going to be counseled for family planning services and if decide to take any method, they will be linked to family planning services

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

counseling

Mothers presented to infant immunization units are going to be counseled for family planning services and if decide to take any method, they will be linked to family planning services

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all women visiting health facilities for infant immunization for at least two times will be included.

Exclusion Criteria

* Women who are in difficulty of communicating during the study period will be excluded.
Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hawassa University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Abebaw Abeje Muluneh

Mr.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Abebaw Muluneh

Role: PRINCIPAL_INVESTIGATOR

Hawassa University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sidama regional health bureau

Awasa, Sidama Region, Ethiopia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Ethiopia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

abe16muluneh

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Birth Control to Improve Birth Spacing
NCT05240066 ACTIVE_NOT_RECRUITING